Use and Prognostic Implications of Cardiac Troponin in COVID-19.
Cardiol Clin
; 40(3): 287-300, 2022 Aug.
Article
in English
| MEDLINE | ID: covidwho-1767946
ABSTRACT
Myocardial injury is common in patients with COVID-19 and is associated with an adverse prognosis. Cardiac troponin (cTn) is used to detect myocardial injury and assist with risk stratification in this population. SARS-CoV-2 infection can play a role in the pathogenesis of acute myocardial injury due to both direct and indirect damage to the cardiovascular system. Despite the initial concerns about an increased incidence of acute myocardial infarction (MI), most cTn increases are related to chronic myocardial injury due to comorbidities and/or acute nonischemic myocardial injury. This review will discuss the latest findings on this topic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Heart Injuries
/
Myocardial Infarction
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Cardiol Clin
Year:
2022
Document Type:
Article
Affiliation country:
J.ccl.2022.03.005
Similar
MEDLINE
...
LILACS
LIS